Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis.

Authors:
Chang YC; Chen YC; Huang CC; Fu CM; Lee YT and 5 more

Journal:
Int J Antimicrob Agents

Publication Year: 2023

DOI:
10.1016/j.ijantimicag.2023.106834

PMCID:
PMC10148756

PMID:
37127127

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Antimicrob Agents

Abbreviation: Int J Antimicrob Agents

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis o…
Tian F; Feng Q; Chen Z. (2023) - Transparency Score: 4/6
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-ass…
Russo A; Bruni A; Gullì S and 12 more (2023) - Transparency Score: 3/6
Prescription of antibiotics by general practitioners for patients with a diagnosis of SARS- CoV-2 i…
Diamantis S; Youbong T; Strazzulla A and 7 more (2023) - Transparency Score: 3/6
The battle against fungi: lessons in antifungal stewardship from COVID 19 times
Kanj SS; Haddad SF; Meis JF and 9 more (2023) - Transparency Score: 3/6
The changes of different restriction level adjustments on antibiotic use in China.
Du K; Wushouer H; Huang T and 7 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability statement: all data generated in this study are available from the corresponding author upon reasonable request. supplementary material associated with this article can be found in the online version at doi"

Code Sharing
Evidence found in paper:

"Competing interests: None declared."

Evidence found in paper:

"Funding: None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025